MediciNova, Inc., a biopharmaceutical firm, stated that it has obtained a Notice of Allowance from the US Patent and Trademark Office for a pending patent application covering MN-166 (ibudilast) for the prevention of metastases in eye cancer...
Glenmark Specialty S.A. (Glenmark), a subsidiary ofGlenmark Pharmaceuticals Ltd., a research-led, global pharmaceutical company, today announced an exclusive marketing and distribution agreementwith BeiGene, a global oncology company. Under this...
Zai Lab Limited, a biotechnology firm, and Innoviva Specialty Therapeutics declared that Zai Lab’s New Drug Application (NDA) for Xacduro (sulbactam-durlobactam) has been approved by China’s National Medical Products Administration (NMPA) for the...
AstraZeneca, a pharmaceutical firm, expects to construct a $1.5 billion manufacturing facility in Singapore for antibody-drug conjugates (ADCs), upgrading the worldwide stockpile of its ADC portfolio. ADCs are cutting-edge therapies that potent...
Implicity announced that company has received 510(k) clearance from the US Food and Drug Administration (FDA) for SignalHF, a new groundbreaking algorithm used in its remote monitoring solution. Implicity was the first...
Glenmark Pharmaceuticals Ltd. (Glenmark) has acquired final approval from the US Food and Drug Administration (FDA) for brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%|0.5%. The FDA has decided that Glenmark's brimonidine...
.jpg)
